To determine whether the TCTP inhibitor sertraline could target prostate cancer stem cells.To investigate the effects of sertraline on in vitro tumorigenesis and metastasis properties while also delineating its anticancer mechanism. The gene discussed is TPT1; the disease is prostate cancer.